Clinical trials recruiting in Albacete, Spain

Phase breakdown

Conditions recruiting in Albacete, Spain

Recruiting trials in Albacete, Spain

• A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
  NCT06578078 · Phase: Phase 3 · Ages: 70 Years and older · Sex: All (male and female)
• A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
  NCT02819882 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
  NCT06686615 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
  NCT05774951 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
  NCT06651567 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female)
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
  NCT06540833 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female)
• A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
  NCT07284121 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
  NCT07282574 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
  NCT04891237 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female)
• Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
  NCT06896266 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• National GMA Post-market Clinical Follow-up Study (GRACE)
  NCT05636709 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
  NCT05232916 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
  NCT07159750 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
  NCT07242547 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• The Impact of Radiotherapy on Oligometastatic Cancer
  NCT05933876 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Albacete, Spain?

17 recruiting trials have at least one study site in Albacete, Spain.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.